The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up
Abstract
BACKGROUND: Recurrence of hepatitis C (HCV) infection after orthotopic liver transplantation (OLT) in HCV-positive patients is almost universal. Severity of graft hepatitis increases during the long-term follow-up, and up to 30% of patients develop severe graft hepatitis and cirrhosis. However, there are still no clear predictors for severe recurrence. The aim of this study was to examine the 10-year outcome and risk factors for graft failure caused by HCV recurrence. METHODS: In a prospective analysis, 234 OLTs in 209 HCV-positive patients with a median age of 53 years were analyzed. Immunosuppression was based on cyclosporine A or tacrolimus in different protocols. Predictors for outcome were genotype, viremia, donor variables, recipient demographics, postoperative immunosuppression, and human leukocyte antigen (HLA) compatibilities. RESULTS: Actuarial 5-, and 10-year patient survival was 75.8% and 68.8%. Eighteen of 209 (8.7%) patients died because of HCV recurrence, which was responsible for 35.9% of the total 53 deaths. Significant risk factors for HCV-related graft failure in an univariate analysis were multiple steroid pulses, use of OKT3, and donor age greater than 40. However, in a multivariate analysis, multiple rejection treatments with steroids and OKT3 treatment proved to be significantly associated with HCV-related graft loss. CONCLUSIONS: The analysis of causes leading to graft failure in patients with HCV showed that HCV recurrence is responsible for one of three deaths in HCV-positive patients. Rejection treatment contributed significantly to an enhanced risk for HCV-related graft loss. New antiviral treatments, as well as adapted immunosuppressive protocols, will be necessary to further improve the outcome of HCV-positive patients after liver transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G., & Williams, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 969
HCV-related fibrosis progression following liver transplantation: increase in recent years
Berenguer, M., Ferrell, L., Watson, J., Prieto, M., Kim, M., Rayón, M., Córdoba, J., Herola, A., Ascher, N., Mir, J., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80231-7 · Cited by 748
(1994) · The Lancet · doi:10.1016/s0140-6736(94)91766-3 · Cited by 656
Predictors of patient and graft survival following liver transplantation for hepatitis C
Charlton, M., Seaberg, E., Wiesner, R., Everhart, J., Zetterman, R., Lake, J., Detre, K., & Hoofnagle, J. (1998) · Hepatology · doi:10.1002/hep.510280333 · Cited by 537
Sheiner, P. A., Schwartz, M. E., Mor, E., Schluger, L. K., Theise, N., Kishikawa, K., Kolesnikov, V., Bodenheimer, H., Emre, S., & Miller, C. M. (1995) · Hepatology · doi:10.1002/hep.1840210107 · Cited by 367
Féray, C., Caccamo, L., Alexander, G. J. M., Ducot, B., Gugenheim, J., Casanovas, T., Loinaz, C., Gigou, M., Burra, P., Barkholt, L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70454-3 · Cited by 354
Quantitation of hepatitis C virus RNA in liver transplant recipients
Chazouilleres, O., Kim, M., Combs, C., Ferrell, L., Bacchetti, P., Roberts, J., Ascher, N. L., Neuwald, P., Wilber, J., Urdea, M., et al. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90759-5 · Cited by 277
Rosen, H. R., Shackleton, C. R., Higa, L., Gralnek, I. M., Farmer, D. A., McDiarmid, S. V., Holt, C., Lewin, K. J., Busuttil, R. W., & Martin, P. B. (1997) · PubMed · Cited by 254
Cited by
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Kato, T., Gaynor, J. J., Yoshida, H., Montalvano, M., Takahashi, H., Pyrsopoulos, N., Nishida, S., Moon, J., Selvaggi, G., Levi, D., et al. (2007) · Transplantation · doi:10.1097/01.tp.0000282914.20578.7b · Cited by 77
Antifibrotic Agents for Liver Disease
Albanis, E., & Friedman, S. L. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01143.x · Cited by 68
Metadata
- Authors
- Neumann, U. P., Berg, T., Bahra, M., Puhl, G., Guckelberger, O., Langrehr, J. M., & Neuhaus, P.
- Venue
- Transplantation
- Published
- 2004-01
- Volume
- 77
- Issue
- 2
- Pages
- 226-231
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1984028098
- Cited by
- 268
- References
- 12
- FWCI
- 29.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. https://app.cochat.ai/papers/10.1097/01.tp.0000101738.27552.9d
- The paper
- Neumann, U. P., Berg, T., Bahra, M., Puhl, G., Guckelberger, O., Langrehr, J. M., & Neuhaus, P. (2004). Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Transplantation. https://doi.org/10.1097/01.tp.0000101738.27552.9d
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.